Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea

PHASE3CompletedINTERVENTIONAL

Enrollment

631

Participants

Timeline

Start Date

December 12, 2013

Primary Completion Date

March 9, 2017

Study Completion Date

May 2, 2017

Conditions

Clostridium Difficile Infection

Interventions

DRUG

Cadazolid

Cadazolid 250 mg as oral suspension twice daily.

DRUG

Vancomycin

Vancomycin 125 mg as oral capsules 4 times daily

DRUG

Cadazolid-matching placebo

Placebo matching cadazolid and administered orally twice daily

DRUG

Vancomycin-matching placebo

Placebo capsules matching vancomycin and administered orally 4 times per day